RB
Rakesh Bhikhalal Shah
About Rakesh Bhikhalal Shah
Data last updated:
Rakesh Bhikhalal Shah is a Director at Kanchan Pharma Private Limited (since 1990), Director at Kepler Healthcare Private Limited (since 2019) and Director at Nava Healthcare Private Limited (since 2023), and holds 13 more current directorships. The companies operate in Transport and Logistics, Pharma and Hospitality & Wellness. The 11 current companies with reported revenue have a combined latest revenue of ₹606 Cr; the largest is Kanchan Pharma Private Limited at ₹274 Cr (FY 2025). Earlier, Rakesh Bhikhalal Shah was a Director at Novelty Healthshine Private Limited (2020–2025) and Director at Rushika Capital Private Limited (2019–2025) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kanchan Pharma Private Limited U24232GJ1990PTC014539 | Director | 16 Oct 1990 | 1990 | ₹274 Cr (FY 2025) | Active |
 Kepler Healthcare Private Limited U24230GJ2013PTC074440 | Director | 02 Dec 2019 | 2013 | ₹185 Cr (FY 2025) | Active |
 Nava Healthcare Private Limited U24233DL2006PTC151081 | Director | 28 Apr 2023 | 2006 | ₹84.21 Cr (FY 2025) | Active |
 Biokindle Lifesciences Private Limited U24233GJ2015PTC082371 | Nominee Director | 11 Apr 2019 | 2015 | ₹42.35 Cr (FY 2025) | Active |
| Rms Infraspace Private Limited U24239GJ2019PTC111571 | Director | 20 Dec 2019 | 2019 | ₹11.10 Cr (FY 2025) | Active |
 Pinkstone Ventures Llp AAQ-9046 | Partner | 04 Oct 2023 | 2019 | ₹6.10 Cr (FY 2026) | Active |
 Equality Healthcare Private Limited U72900GJ2021PTC121292 | Director | 03 Nov 2023 | 2021 | ₹2.82 Cr (FY 2024) | Active |
| Quanterra Stratergies Llp ACD-7805 | Partner | 19 Dec 2023 | 2023 | ₹96.6 Lakh (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novelty Healthshine Private Limited U93090GJ2018PTC121325 | Director | 02 Jan 2020 | 2018 | ₹20.00 Cr (FY 2025) | Active |
| Rushika Capital Private Limited U66190GJ2019PTC111602 | Director | 23 Dec 2019 | 2019 | ₹5.74 Cr (FY 2025) | Active |
| Ember Nest Llp ACE-5121 | Designated Partner | 22 Jul 2024 | 2023 | ₹10,323 (FY 2026) | Active |
 Eris Lifesciences Limited L24232GJ2007PLC049867 | Director | 25 Jan 2007 | 2007 | ₹5,069 Cr (FY 2025) | Active |
 Eris Therapeutics Private Limited U24230GJ2009PTC057670 | Director | 30 Jul 2009 | 2009 | Amalgamated | |
| Prima Infraspace Private Limited U45200GJ2011PTC063842 | Director | 15 Dec 2011 | 2011 | ₹5 Lakh (FY 2017) | Active |
| Morvi Resorts And Farms Pvt Ltd U55200MH1991PTC060913 | Nominee Director | 01 Dec 2023 | 1991 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rakesh Bhikhalal Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakesh Bhikhalal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakesh Bhikhalal Shah
Rakesh Bhikhalal Shah currently holds 16 directorships: Kanchan Pharma Private Limited (Director, since 16 Oct 1990, revenue ₹274 Cr (FY 2025)); Kepler Healthcare Private Limited (Director, since 02 Dec 2019, revenue ₹185 Cr (FY 2025)); Nava Healthcare Private Limited (Director, since 28 Apr 2023, revenue ₹84.21 Cr (FY 2025)); Biokindle Lifesciences Private Limited (Nominee Director, since 11 Apr 2019, revenue ₹42.35 Cr (FY 2025)); Rms Infraspace Private Limited (Director, since 20 Dec 2019, revenue ₹11.10 Cr (FY 2025)); and 11 more.
Rakesh Bhikhalal Shah was first appointed on 16 Oct 1990 as Director at Kanchan Pharma Private Limited. The most recent appointment on record is 21 Jul 2026 at Nava Pharmacare Private Limited.
The 11 current companies of Rakesh Bhikhalal Shah that report revenue have a combined latest revenue of ₹606 Cr: Kanchan Pharma Private Limited ₹274 Cr (FY 2025); Kepler Healthcare Private Limited ₹185 Cr (FY 2025); Nava Healthcare Private Limited ₹84.21 Cr (FY 2025); Biokindle Lifesciences Private Limited ₹42.35 Cr (FY 2025); Rms Infraspace Private Limited ₹11.10 Cr (FY 2025); and 6 more.
Rakesh Bhikhalal Shah held 7 earlier board appointments: Novelty Healthshine Private Limited (Director, 02 Jan 2020 to 16 Sep 2025); Rushika Capital Private Limited (Director, 23 Dec 2019 to 27 May 2025); Ember Nest Llp (Designated Partner, 22 Jul 2024 to 19 Nov 2024); Eris Lifesciences Limited (Director, 25 Jan 2007 to 07 Feb 2012); Eris Therapeutics Private Limited (Director, 30 Jul 2009 to 07 Feb 2012); and 2 more.
The current boards of Rakesh Bhikhalal Shah's companies include Bhikhalal Chimanlal Shah (Kanchan Pharma Private Limited), Mona Jitendrakumar Shah (Kanchan Pharma Private Limited), Rushabh Rakeshbhai Shah (Kanchan Pharma Private Limited), Rushika Shah (Kanchan Pharma Private Limited), Harpal Bhikhabhai Vala (Kepler Healthcare Private Limited), Meenu Arya (Nava Healthcare Private Limited), among others.